/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
14 November 2018 Subject: Management Discussion and Analysis for the Nine-Month Period Ended September 30, 2018 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public
2019 To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results of the Company and its subsidiaries
26 October 2020 To: The President The Stock Exchange of Thailand Re: Q3-2020 Operating Results We, Delta Electronics (Thailand) Public Company Limited (the “Company”) would like to notify the
27 April 2021 To: The President The Stock Exchange of Thailand Re: Q1-2021 Operating Results We, Delta Electronics (Thailand) Public Company Limited (the “Company”) would like to notify the Company’s
Microsoft Word - 011 ชี้แจงกำไรE (Translation) IR 011/19 August 9, 2019 President and Director The Stock Exchange of Thailand Subject : To explain the reasons on the company’s net profit (net loss
Manager of the Stock Exchange of Thailand For the Q2/2019 period ended of June 30, 2019 (3 months) operating result of the company net loss Baht 6.47 Million comparison with the previous Q2/2018’s net loss
(Translation) (Translation) IR 015/18 August 9, 2018 President and Director The Stock Exchange of Thailand Subject : To explain the reasons on the company’s net profit (net loss) more than 20% from
หนา้ 1/1 (Translation) Ref. JCKH 024/2561 14 August 2018 Subject: Management Discussion and Analysis for the Quarter 2/2018 To: The President The Stock Exchange of Thailand CC: The Secretary General
). With the referral from the Stock Exchange of Thailand on irregular trading of UNIQ shares as a result of trading orders sent via two overseas omnibus accounts causing the changes of UNIQ share price and